LivaNova PLC

LIVNNASDAQ · USD
76.99USD-0.22 (-0.29%)
799

LivaNova PLC (LIVN) Wheel Strategy

LIVN wheel strategy scan found 25 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 46.3%.

Read more

Running a LIVN wheel strategy lets you generate consistent premium income on LivaNova PLC while setting your own entry and exit prices on the underlying. LivaNova PLC's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own LIVN, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best LIVN wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on LIVN, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable LIVN wheel from a losing one.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea.

It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the LIVN wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your LIVN wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202672.50$0.25$2.03-0.332223%64.8%46.3%1
Oct 16, 202675.00$0.40$2.05-0.442223%51.4%45.3%3
Nov 20, 202672.50$1.70$3.50-0.365723%58.3%30.9%0
Nov 20, 202670.00$1.35$2.83-0.305723%66.6%25.8%0
Dec 18, 202672.50$2.50$4.20-0.368523%56.2%24.9%0
Jan 15, 202772.50$3.50$5.25-0.3711323%54.8%23.4%7
Dec 18, 202670.00$1.55$3.43-0.318523%63.1%21.0%1
Dec 18, 202667.50$1.55$3.23-0.268523%69.9%20.5%0
Dec 18, 202665.00$0.90$2.80-0.228523%76.3%18.5%0
Jan 15, 202770.00$1.90$3.75-0.3111323%60.9%17.3%0

As of September 28, 2026

Run the Wheel on LIVN With Confidence

Find the best LIVN wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial